Evidence map›Paper›PMID 30473937›Full record

ArticlePeerJ2018

CMTCN: a web tool for investigating cancer-specific microRNA and transcription factor co-regulatory networks.

Ruijiang Li, Hebing Chen, Shuai Jiang, Wanying Li, Hao Li, Zhuo Zhang, Hao Hong, Xin Huang, Chenghui Zhao, Yiming Lu and 1 more

Open access · goldAbstract read
In one paragraph

Article in PeerJ, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
0.9field-weighted citation impact, top 25% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 11 citations in OpenAlex.

  1. MicroRNA Databases and Tools.Methods in molecular biology (Clifton, N.J.) · 2022
    Article
  2. Review
  3. Article
  4. Review
  5. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Ruijiang Li *Department of Biotechnology, Beijing Institute of Radiation Medicine, Beijing, China.
Hebing Chen *Department of Biotechnology, Beijing Institute of Radiation Medicine, Beijing, China.
Shuai JiangDepartment of Biotechnology, Beijing Institute of Radiation Medicine, Beijing, China.
Wanying LiDepartment of Biotechnology, Beijing Institute of Radiation Medicine, Beijing, China.
Hao LiDepartment of Biotechnology, Beijing Institute of Radiation Medicine, Beijing, China.
Zhuo ZhangDepartment of Biotechnology, Beijing Institute of Radiation Medicine, Beijing, China.
Hao HongDepartment of Biotechnology, Beijing Institute of Radiation Medicine, Beijing, China.
Xin HuangDepartment of Biotechnology, Beijing Institute of Radiation Medicine, Beijing, China.
Chenghui ZhaoDepartment of Biotechnology, Beijing Institute of Radiation Medicine, Beijing, China.
Yiming LuDepartment of Biotechnology, Beijing Institute of Radiation Medicine, Beijing, China.
Xiaochen BoDepartment of Biotechnology, Beijing Institute of Radiation Medicine, Beijing, China.
Beijing Radiation Center · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Transcription factors (TFs) and microRNAs (miRNAs) are well-characterized trans-acting essential players in gene expression regulation. Growing evidence indicates that TFs and miRNAs can work cooperatively, and their dysregulation has been associated with many diseases including cancer. A unified picture of regulatory interactions of these regulators and their joint target genes would shed light on cancer studies. Although online resources developed to support probing of TF-gene and miRNA-gene interactions are available, online applications for miRNA-TF co-regulatory analysis, especially with a focus on cancers, are lacking. In light of this, we developed a web tool, namely CMTCN (freely available at http://www.cbportal.org/CMTCN), which constructs miRNA-TF co-regulatory networks and conducts comprehensive analyses within the context of particular cancer types. With its user-friendly provision of topological and functional analyses, CMTCN promises to be a reliable and indispensable web tool for biomedical studies.

Indexed as

CancerCo-regulationMicroRNANetworkTranscription factorWeb tool

Identifiers

PMID30473937
PMCPMC6237116
OpenAlexW2901079885

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.